PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91025P00462 — STABILITY TESTING SERVICES AND DRUG MASTER FILE MAINTENANCE FOR ANTIBODY DRUG CONJUGATE ADCT-701

STABILITY TESTING SERVICES AND DRUG MASTER FILE MAINTENANCE FOR ANTIBODY DRUG CONJUGATE ADCT-701 is a federal NONE award for Department of Health and Human Services (HHS) held by ADC THERAPEUTICS AMERICA, INC.. Estimated value $194K ($194K obligated). Current period of performance ends Dec 29, 2027. Last award drew 1 bidder. Place of performance: NEW PROVIDENCE NJ.

$194K
Estimated Value
Dec 29, 2027
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

ADC THERAPEUTICS AMERICA, INC. holds $194K across 2 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Dec 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75N91025P00462
AgencyDepartment of Health and Human Services (HHS)
IncumbentADC THERAPEUTICS AMERICA, INC.
CAGE8WNM0
UEIY9MBZX2C5RU5
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Place of performanceNEW PROVIDENCE NJ
Pricing typeFirm Fixed Price
Extent competedNot Competed
PoP startSep 29, 2025
PoP end (current)Dec 29, 2027
Obligated$194K
Current value$194K
Potential value$194K

STABILITY TESTING SERVICES AND DRUG MASTER FILE MAINTENANCE FOR ANTIBODY DRUG CONJUGATE ADCT-701

Recompete timing

Public
Expiring in 496 days

Current PoP ends Dec 29, 2027 (496 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jun 29, 2026.

Watch this contract — one email →

Incumbent footprint

Public record

ADC THERAPEUTICS AMERICA, INC.$194K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$194K · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75N91025P00462
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open ADC THERAPEUTICS AMERICA, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75N91025P00462?

75N91025P00462 (STABILITY TESTING SERVICES AND DRUG MASTER FILE MAINTENANCE FOR ANTIBODY DRUG CONJUGATE ADCT-701) is a Department of Health and Human Services (HHS) award with an estimated value of $194K, currently held by ADC THERAPEUTICS AMERICA, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75N91025P00462?

ADC THERAPEUTICS AMERICA, INC. is the incumbent with $194K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Dec 29, 2027.

When does 75N91025P00462 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91025P00462

SCOUT Signal

August 2026

One VA health contract was 35% of civilian federal obligations in July.

Meanwhile VA's service-disabled veteran-owned contract actions fell 41.8%. The same agency, the same month, the large-vendor lane expanding while the small-business lane contracted. Figures are civilian-agency obligations through 2026-07-31; DoD FPDS for this window is labeled incomplete.

This issue is the whole civilian market. Your capture plan isn't.

Read the August 2026 issue →